| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 7, 2026 | WRBY Warby Parker Inc. | Blumenthal Neil Harris65 | Co-chief Executive Officer | Sell | 50,000 | $27.08 | $1,354,000.00 | -57.4% | -21.7% | - | |
| Jan 7, 2026 | OM Outset Medical, Inc. | Trigg Leslie84 | Chair And CEO | Sell | 1,795 | $4.27 | $7,664.65 | -1.5% | -5.5% | - | |
| Jan 7, 2026 | OM Outset Medical, Inc. | Nash Marc83 | EVP Operations R&D &Service | Sell | 108 | $4.27 | $461.16 | -0.2% | -5.5% | - | |
| Jan 7, 2026 | BFLY Butterfly Network, Inc. | Doherty John N.75 | EVP, CFO | Sell | 60,182 | $3.98 | $239,524.36 | -4.6% | -3.8% | - | |
| Jan 7, 2026 | RMD Resmed Inc | Farrell Peter C57 | Director | Sell | 2,000 | $248.83 | $497,660.00 | -2.9% | -8.9% | - | |
| Jan 7, 2026 | RMD Resmed Inc | Farrell Michael J.63 | Chairman And CEO | Sell | 4,991 | $248.46 | $1,240,065.36 | -1.1% | -8.9% | - | |
| Jan 7, 2026 | INCY Incyte Corp | Issa Mohamed Khairie | EVP, Head Of Us Oncology | Sell | 10,856 | $109.07 | $1,184,063.92 | -14.1% | -15.3% | - | |
| Jan 7, 2026 | LUCY Innovative Eyewear Inc | Galkin Vladimir45 | 10% Owner | Buy | 647,505 | $1.79 | $1,155,953.95 | -16,188% | -37.9% | - | |
| Jan 6, 2026 | BLFS Biolife Solutions Inc | Berard Todd67 | Chief Marketing Officer | Sell | 344 | $25.59 | $8,802.96 | -0.3% | -26.9% | - | |
| Jan 6, 2026 | MMSI Merit Medical Systems Inc | Peterson Neil W.51 | Chief Operating Officer | Sell | 5,000 | $90.00 | $450,000.00 | -15.0% | -27.1% | - | |
| Jan 6, 2026 | EKSO Ekso Bionics Holdings, Inc. | Jones Jason C64 | Chief Operating Officer | Sell | 1,320 | $9.25 | $12,210.00 | -4.9% | +2.3% | - | |
| Jan 6, 2026 | BLFS Biolife Solutions Inc | Aebersold Sarah60 | Chief Human Resources Officer | Sell | 241 | $25.59 | $6,167.19 | -0.3% | -26.9% | - | |
| Jan 6, 2026 | BLFS Biolife Solutions Inc | Foster Karen A.67 | Chief Quality And Operations | Sell | 335 | $25.59 | $8,572.65 | -0.2% | -26.9% | - | |
| Jan 6, 2026 | BLFS Biolife Solutions Inc | Mathew Aby J.68 | EVP &Chief Scientific Officer | Sell | 405 | $25.59 | $10,363.95 | -0.1% | -26.9% | - | |
| Jan 6, 2026 | EW Edwards Lifesciences Corp | Bobo Donald E Jr64 | Cvp,Strategy/ Corp Development | Sell | 11,340 | $85.66 | $971,429.16 | -13.5% | -5.4% | - | |
| Jan 6, 2026 | BBNX Beta Bionics, Inc. | Mensinger Mike73 | Chief Product Officer | Sell | 2,200 | $30.10 | $66,221.10 | -2.7% | -68.3% | - | |
| Jan 6, 2026 | PEN Penumbra Inc | Grewal Harpreet60 | Director | Sell | 186 | $312.64 | $58,151.04 | -2.2% | +4.1% | - | |
| Jan 6, 2026 | WRBY Warby Parker Inc. | Blumenthal Neil Harris65 | Co-chief Executive Officer | Sell | 150,000 | $25.09 | $3,763,500.00 | -36.5% | -18.9% | - | |
| Jan 6, 2026 | SGHT Sight Sciences, Inc. | Taylor Brenton74 | EVP, Operations &R&D | Sell | 619 | $7.48 | $4,630.12 | -0.4% | -52.5% | - | |
| Jan 6, 2026 | BLFS Biolife Solutions Inc | Wichterman Troy60 | Chief Financial Officer | Sell | 990 | $25.59 | $25,334.10 | -0.7% | -26.9% | - | |
| Jan 6, 2026 | SGHT Sight Sciences, Inc. | Rodberg James54 | Chief Financial Officer | Sell | 4,999 | $7.78 | $38,890.22 | -1.6% | -52.5% | - | |
| Jan 6, 2026 | SGHT Sight Sciences, Inc. | Hayden Jeremy B.61 | Chief Legal Officer | Sell | 11,170 | $7.77 | $86,742.50 | -2.2% | -52.5% | - | |
| Jan 6, 2026 | MOVE Movano Inc. | Cogan Jeremy | CFO | Sell | 10,097 | $7.89 | $79,675.05 | -14.8% | -2.1% | - | |
| Jan 6, 2026 | SGHT Sight Sciences, Inc. | Bauerlein Alison71 | Chief Operating Officer | Sell | 20,543 | $7.66 | $157,366.28 | -1.7% | -52.5% | - | |
| Jan 6, 2026 | SGHT Sight Sciences, Inc. | Badawi David58 | Chief Technology Officer | Sell | 9,660 | $7.57 | $73,148.44 | -0.2% | -52.5% | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.